On 28 October 2025, Jiangsu Hengrui Pharmaceuticals Co., Ltd. (stock code 600276) reported the repurchase of 1,186,000 A shares on the Shanghai Stock Exchange for its A Share Employee Stock Ownership Schemes. The highest repurchase price reached RMB 64.01 per share, and the lowest stood at RMB 63.61 per share, with a total transaction amount of approximately RMB 75.77 million.
After this transaction, the number of treasury shares rose from 14,811,110 to 15,997,110, while the number of issued shares (excluding treasury shares) decreased from 6,364,191,164 to 6,363,005,164. The total number of issued shares remains at 6,379,002,274 as of 28 October 2025.